Mysore Varsity faculty s lab develops new breast cancer drug-like compounds starofmysore.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from starofmysore.com Daily Mail and Mail on Sunday newspapers.
The yeast
Candida albicans can cause itchy, painful urinary tract and vaginal yeast infections. For women in low-resource settings who lack access to healthcare facilities, these infections create substantial social and economic burdens. Now, researchers reporting in
ACS Omega have developed color-changing threads that turn bright pink in the presence of
C. albicans. When embedded in tampons or sanitary napkins, they could allow women to quickly and discreetly self-diagnose vulvovaginal yeast infections, the researchers say.
According to the Mayo Clinic, about 75% of women will experience a yeast infection, or vulvovaginal candidiasis, at least once in their lifetime. Although women in high-resource areas can easily be diagnosed with a vaginal swab at their doctor s office and then treated with an antifungal medication, many women throughout the world lack access to basic healthcare facilities. Moreover, in some resource-limited areas, societal taboos cause women to feel shame
Picture used for representational purpose only
MYSURU: Assistant professor Basappa, HoD, organic chemistry department of the University of Mysore (UoM) has discovered a new drug-seed in lab conditions for breast cancer.
The new drug-seed named AMTA has been developed after five years of research, which Basappa claims is effective in breast cancer treatment. “The breast cancer cells are now developing resistance to a few treatments. This drug-seed has been found effective against breast cancer in lab conditions. In the next phase, trials will be conducted on animals and later the clinical trials will be taken up,” he explained.
According to Basappa, AMTA has been found to be better when compared to Tamoxifen which is one of the drugs approved for the breast cancer treatment.